Print this page|
MIDDLEFIELD HEALTHCARE DIVIDEND FUND Summary of Investment Portfolio as at September 30, 2023 |
||||
| Top Twenty-Five Holdings | ||||
| Description |
% of Net Asset Value |
|||
| 1. | Eli Lilly & Co. | 6.3% | ||
| 2. | UnitedHealth Group Inc | 4.8% | ||
| 3. | Merck & Co., Inc. | 4.5% | ||
| 4. | Thermo Fisher Scientific Inc. | 4.5% | ||
| 5. | Abbvie Inc. | 4.4% | ||
| 6. | AstraZeneca PLC | 4.4% | ||
| 7. | Chartwell Retirement Residences | 4.0% | ||
| 8. | Stryker Corp. | 3.8% | ||
| 9. | Medtronic PLC | 3.5% | ||
| 10. | Becton Dickinson & Co. | 3.4% | ||
| 11. | Sanofi | 3.3% | ||
| 12. | Danaher Corp. | 3.3% | ||
| 13. | Johnson & Johnson | 3.3% | ||
| 14. | Boston Scientific Corp. | 3.1% | ||
| 15. | Pfizer Inc. | 2.9% | ||
| 16. | Abbott Laboratories | 2.9% | ||
| 17. | Zoetis Inc. | 2.8% | ||
| 18. | Gilead Sciences Inc. | 2.8% | ||
| 19. | Novo Nordisk A/S | 2.7% | ||
| 20. | Mckesson Corp. | 2.6% | ||
| 21. | Edwards Lifesciences Corp. | 2.3% | ||
| 22. | Intuitive Surgical Inc. | 2.2% | ||
| 23. | Humana Inc. | 2.2% | ||
| 24. | DexCom Inc. | 2.1% | ||
| 25. | Vertex Pharmaceutical Inc. | 2.1% | ||
| "Top Twenty-Five Holdings" excludes any temporary cash investments | ||||
| Asset Class | % of Net Asset Value |
|||
| Healthcare | 91.2% | |||
| Real Estate | 5.8% | |||
| Consumer Staples | 1.6% | |||
| Cash and Short-Term Investments | 1.9% | |||
| Other Assets (Liabilities) | -0.5% | |||
| 100.0% | ||||
| Total Net Asset Value | $91,892,776 | |||
| Total Assets | $92,598,848 | |||
| The Summary of Investment Portfolio may change due to ongoing portfolio transactions.Updates to this Summary of Investment Portfolio are posted to www.middlefield.com. | ||||